Barlow Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Buy |
50,958
+865
| +2% | +$395K | 2.79% | 13 |
|
|
2025
Q1 | $24.7M | Buy |
50,093
+383
| +0.8% | +$189K | 3.25% | 8 |
|
|
2024
Q4 | $21.1M | Buy |
49,710
+2,138
| +4% | +$907K | 2.67% | 11 |
|
|
2024
Q3 | $21.3M | Buy |
47,572
+563
| +1% | +$253K | 2.79% | 9 |
|
|
2024
Q2 | $23.1M | Buy |
47,009
+796
| +2% | +$391K | 3.19% | 7 |
|
|
2024
Q1 | $18.3M | Buy |
46,213
+1,247
| +3% | +$494K | 2.49% | 11 |
|
|
2023
Q4 | $18.3M | Buy |
+44,966
| New | +$18.3M | 2.6% | 9 |
|